Aspirin in Transient Ischemic Attacks "AITIA"

Completed

Phase N/A Results

Summary of Purpose

To determine whether aspirin has a clinical benefit in the prevention of arterial thromboembolism and its consequences.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Heart, Lung, and Blood Institute, NIH

Trial Design

Double-blind, placebo-controlled, multicenter trial of 303 patients at 10 centers.

Contacts

Not available